Anti-REV Envelope Glycoprotein Polyclonal Antibody from ProteoGenix; catalogue ARO-A22242; research use only.
Know who made it. See the evidence. Buy through one marketplace.
The Anti-REV Envelope Glycoprotein Polyclonal Antibody is a powerful tool for biotech researchers looking to study the role of REV envelope glycoprotein in various biological processes. This highly specific antibody targets the REV envelope glycoprotein, allowing for precise and accurate analysis of its function.
The REV envelope glycoprotein plays a crucial role in the life cycle of retroviruses, including HIV. This protein is responsible for mediating viral entry into host cells, making it a key target for antiviral therapies. By using the Anti-REV Envelope Glycoprotein Polyclonal Antibody, researchers can gain a deeper understanding of the mechanisms involved in viral entry and potentially develop new treatments for retroviral infections.
This antibody is also useful for studying the role of REV envelope glycoprotein in other biological processes, such as cell signaling and immune response. Its high specificity and sensitivity make it an ideal tool for a wide range of applications in the field of biotechnology.
In experimental use cases, the Anti-REV Envelope Glycoprotein Polyclonal Antibody has been shown to effectively detect and bind to REV envelope glycoprotein in various cell types and tissues. This allows for detailed analysis of the protein’s expression, localization, and interactions with other molecules.
ProteoGenix catalogue number ARO-A22242. For research use only.
Target: Envelope glycoprotein, Env polyprotein; Clonality: Polyclonal Antibody; Applications: IHC, ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Envelope glycoprotein, Env polyprotein |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
